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To perform single-molecule studies of the T7 RNA polymerase, it is crucial to visualize an individual T7 RNA polymerase, for
example, through a fluorescent signal. We present a novel complex combining two different molecular functions, an active T7 RNA
polymerase and a highly luminescent nanoparticle, a quantumdot.The complex has the advantage of both constituents: the complex
can traffic along DNA and simultaneously be visualized, both at the ensemble and at the single-molecule level. The labeling was
mediated through an in vivo biotinylation of a His-tagged T7 RNA polymerase and subsequent binding of a streptavidin-coated
quantum dot. Our technique allows for easy purification of the quantum dot labeled T7 RNA polymerases from the reactants. Also,
the conjugation does not alter the functionality of the polymerase; it retains the ability to bind and transcribe.
1. Introduction
RNA polymerase (RNAP) is an enzyme that catalyses tran-
scription. It shall balance two tasks: binding to specific sites
on DNA where transcription is initiated (promoters) and the
ability to disengage at the termination signals. Proteins and
other cofactors can inhibit or recruit RNAPs to DNA, thus
regulating the initiation process.
Several families of RNAPs exist which differ in theirmole-
cular characteristics. The viral T7 RNA polymerase is a
single subunit RNAP (98 kDa) [1] characterized by extreme
promoter specificity [2] and a very low error rate [3]. The
T7 family of RNAPs is structurally and evolutionary distinct
from the multisubunit family of RNAPs. T7 RNAP allows
specific high-level transcription and expression of cloned
genes [4]; therefore, it is a key enzyme in the production
of recombinant proteins and also in several in vitro molec-
ular biology applications [5, 6]. Such applications include
the generation of large quantities of RNA transcripts for
translation, synthesis of tRNA, rRNA, RNA virus genomes,
ribozymes, microarray targets [7], production of substrates
for RNA splicing [8], RNA secondary structure, antisense
RNA, and RNA-protein interaction studies. The T7 RNAP
is suitable for homogeneous radioactive or nonradioactive
labeling of single-stranded RNA, and it plays an important
role in technologies based on RNA and DNA hybridization
[9]. Tight regulation of T7 RNAP expression is possible and
T7 systems are therefore used for the production of otherwise
deleterious protein products [10].
Awide variety of assays are designed to study the diffusive
or directed translocation of molecular motors. In order to
visualize or manipulate the individual motor, it is typically
conjugated to a fluorescent probe or a dielectric particle. An
effective conjugation, which does not alter the activity of the
enzyme, is absolutely essential in order to obtain trustworthy
results.
Due to their high quantum yield and large photostability
[11–14] colloidal quantum dots (QDs) are a particularly good
choice as labels for molecular motors. QDs have been used,
for example, to track the motility of individual receptors
in a cell membrane [15], to track individual bacteriophages
infecting bacteria [16] and to monitor individual proteins
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T7 RNA polymerase
GLNDIFEAQKIEWH-GSS-HHHHHH-SSGLVPRGSHMLE-MNTI. . .
Figure 1: N-terminal amino acid sequence of the biotinylated T7
RNAP. The N-terminal part of the enzyme begins with a 15aa
sequence recognized by biotin ligase. Then follows a 3aa spacer and
the His6-tag whereupon the aa sequence of the T7 RNAP begins.
diffusing on DNA [17, 18]. Individual colloidal QDs can even
be opticallymanipulated [19] and excited by the trapping laser
through two-photon absorption [20], thus enabling both
visualization and manipulation through specific attachment
of a single QD. For these reasons, it is highly desirable to
devise a method to specifically attach QDs to individual
molecular motors. QDs can be taken up by living cells [21]
and are nontoxic when encapsulated. Hence, they also have
potential for in vivo studies of, for example, the action of
molecular motors.
Here, we devise a technique to specifically label individual
T7 RNAPs by QDs through a biotin-streptavidin bond,
and we show that the QD-functionalized T7 RNAP (QD :
T7RNAP) retains activity. Previously, activity was proven of a
QD-labelled E. coli RNAP [22], and activity was proven of T7
RNAP bioconjugated to polystyrene beads [23]; however, to
our knowledge this is the first report of QD labelling of viral
T7 RNAPs that retain activity after QD marking. Moreover,
our applied purification technique is simple, inexpensive, and
very efficient.
2. Materials and Methods
2.1. In Vivo Biotinylation and Purification of T7 RNAP. Our
construct was based on plasmid pBH161 which was a gener-
ous gift fromWilliamT.McAllister, Department of Biochem-
istry, University of NewHampshire. Plasmid pBH161 encodes
a T7 RNAP His-tagged N terminally [24]. We further tagged
the enzyme N terminally with the GLNDIFEAQKIEWH
sequence, referred to as a biotag, which was recognized by
biotin ligase and biotinylated at a single lysine in vivo [25]
(Figure 1). The DNA sequence encoding the Bio-tag was
synthesized by PCR using three overlapping primers:
5󸀠-ATCACCATGGGTAGCAGCGGCCTGAAC-
GACATCTTCGAAGCTCAGAAAA-3󸀠.
5
󸀠-ATCTTCGAAGCTCAGAAAATTGAATGG-
CACGGCAGCTCTCATCATCATCATCATCAT-
AG-3󸀠.
5
󸀠-ATAGCTCGAGCATATGAGAACCGCGCG-
GCACCAGACCACTGCTATGATGATGATGAT-
GATGAG-3󸀠.
The synthesizedDNA fragment was digested by XhoI and
NcoI and inserted between the XhoI andNcoI sites in pBH161
upstream of the sequence encoding the His-tag; the resulting
plasmid was denoted as pBioT7. Bio-His-tagged T7 RNAP
(Bio-T7 RNAP) was expressed in the E. coli strain BL21Star
(Invitrogen) containing the plasmids: pBioT7 and pBirA
(Avidity), which expresses biotin-holoenzyme-synthetase
activities. Enzymes were purified from the lysate using Ni2+-
agarose beads (Qiagen) and eluted with 80mM imidazol.
2.2. Quantification of Biotinylation of T7 RNAP. To quantify
the amount of Bio-T7 RNAPs, purified Bio-T7 RNAPs were
mixed with SoftLink Soft Release Avidin Resin (Promega)
and allowed to bind for 1 hour at room temperature. The
mixture was loaded on Poly-Prep Chromatography Columns
(Bio-Rad) and the flow-through was collected. The column
was washed with 10 bed volumes of buffer (20mM Tris-
HCl pH 7.9, 0.5M NaCl, 0.05% (w/v) Tween 20). Samples
of the flow-through, the washed fraction, and the matrix-
bound fractions were loaded on a 4–12% NuPAGE gel
(Invitrogen) along with a molecular weight marker (SeeBlue
Plus2, Invitrogen).The control protein (Phage 16-3 repressor,
C16-3) was not biotinylated. After electrophoresis the gel was
stained with Coomassie Brilliant Blue.
2.3. Estimation of Concentration of Biotinylated T7 RNAPs.
We used the ExPASy ProtParam tool (expasy.org) [26] to
calculate the theoretical extinction coefficient of the Bio-
T7 RNAP to 145760 1/M∗cm. The absorbance was measured
using a NanoDrop spectrophotometer (ThermoScientific).
The enzyme preparation also included impurities (Figure S1,
see supplementary material available online at http://dx.doi
.org/10.1155/2013/468105) of unknown extinction coefficient.
The approximate enzyme concentration was estimated using
the measured absorbance and Beer-Lamberts equation.
2.4. Verification of Activity of Biotinylated T7 RNAPs. The in
vivo biotinylated T7 RNAPs were immersed in a reaction
mixture containing 2 ng/𝜇L 1,000 bp DNA template with
T7 promoter and terminator, transcription buffer (40mM
Tris-HCl pH 7.9, 6mM MgCl
2
, and 10mM NaCl), 2mM
spermidine, 10mM DTT, 2mM of each rNTP, 2 units/𝜇L
RNasin, and 2.6 𝜇MBio-T7 RNAP.The reaction mixture was
incubated at 37∘C for 1 hour and loaded onto a 1.8% agarose
gel and stained with ethidium bromide.
2.5. Formation of QD : T7RNAP Complexes. The Bio-T7
RNAPs were attached to QDs in the following manner. In a
final volume of 30 𝜇L 0.13, 0.091, or 0.052 nmol of the Bio-T7
RNAPweremixedwith 10mMDTT, transcription buffer, and
0.01 nmol streptavidin-coated QDs (Qdot605, Invitrogen).
The mixture was left at 4∘C for 1.5 hour allowing the
streptavidin-biotin bonds to form. Parallel controls consisted
of the same solution with Bio-T7 RNAPs but without QDs
present.
2.6. Purification of QD : T7RNAPComplexes. In order to pur-
ify the QD : T7RNAP complexes 20𝜇L transcription buffer
was added to the QD : T7RNAP and control solutions. Each
of the final 50 𝜇L reactions was transferred to 25𝜇L avidin
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Figure 2: Separation of QD : T7RNAP complexes from free RNAPs.
The Bio-T7 RNAPs are mixed with streptavidin-coated QDs thus
forming QD : T7RNAP complexes.The suspension is mixed with an
avidin resin to capture the remaining free Bio-T7 RNAPs. Once the
suspension is centrifuged on a 0.45𝜇mfilter only the QD : T7RNAP
complexes and free QDs reach the bottom.
resin, prewashed and centrifuged.The resinwas resuspended,
and put on a shaker at 4∘C for 1 hour. The avidin and
QD : T7RNAP suspensions were filter-centrifuged (pore size
0.45 𝜇m, Pierce), only allowing the QD : T7RNAP and the
free QDs to be in the flow-through, which was collected for
an activity test (Figure 2). The avidin resins were washed
with 100 𝜇L transcription buffer and resuspended in 10 𝜇L
transcription buffer and also collected for an activity test.
2.7. Activity of QD : T7RNAP Complexes and Avidin-Bound
RNAPs. A 1,000 bp T7 RNAP transcription template was
made by PCR on pJT512 (the 11/6 construct of Tholstrup et
al.2012 [27]). Forward primer was TH414:
5
󸀠-TAATACGACTCACTATAGGGAGAGTATACC-
TCTCAGTTGGGTG-3󸀠
(underlined is overhang containingT7 promotor) and the
reverse primer, TH412, had the sequence:
5󸀠-ATAATTCGCGTCTGGCCTTC.
This template supports a 1000 nt long transcript from the
promoter to the end of the fragment. All activity tests were
made with this template, except in Figures 4(b) and 4(c)
where the template pMAS30 (plasmid encoding upstream
lacZ riboprobe [27]), digested with SacI, was used. This T7
RNAP template supports a 830 nt long transcript.
Activity tests were performed of both the flow-through
containing QD : T7RNAP complexes and of the washed
avidin resin containing Bio-T7 RNAPs bound to the avidin
resin. The reaction mixture (10 𝜇L) contained 2 ng/𝜇L,
1,000 bp DNA template with a T7 promoter, transcription
buffer, 2mM spermidine, 10mM DTT, 2mM of each rNTP,
2 units/𝜇L RNasin, and 6𝜇L of collected QD : T7RNAP solu-
tion. The reaction mixture was incubated at 37∘C for 1 hour
and loaded on a 1.8% agarose gel. The two controls consisted
of 0.026 nmol Bio-T7 RNAPs in transcription buffer and
1 pmol QDs in transcription buffer.
As each QD is coated with 6–8 streptavidins (Invit-
rogen), the average number of Bio-T7 RNAPs bound to
each QD can be controlled by adjusting Bio-T7 RNAP and
QD concentrations. The RNA product of the activity test
should not derive from free Bio-T7 RNAPs. In order to
find the amount of RNA product originating from free Bio-
T7 RNAPs, controls undergoing the same procedure as the
samples, but with noQDs, revealed the amount of free Bio-T7
RNAPs escaping the avidin resin in the flow-through. In this
way the concentrations of Bio-T7 RNAPs and QDs yielding
optimal working conditions, that is, an absolute minimum of
free Bio-T7 RNAPs, were found.
2.8. T7 RNAP Streptavidin Control. A gel filtration was per-
formed in order to exclude the possibility that active
QD : T7RNAPs were only attached to streptavidin (and not
to a QD). In this experiment 0.385 nmol Bio-T7 RNAP was
mixed with 0.075 nmol QDs (Bio-T7 RNAP :QD ≃ 5 : 1) in a
final volume of 110 𝜇L, and the solution was left at 4∘C for 1.5
hour to allow the formation of complexes. The solution was
filtered through a Superose 6 10/300GL column on BioRad
BioLogic DuoFlow at a flow rate of 0.5mL/minute tran-
scription buffer. 0.5mL fractions were collected with BioRad
BioLogic BioFrac Fraction Collector. Controls without QDs
were processed similarly using 2.137 nmol and 0.385 nmol
Bio-T7 RNAP, respectively.
An activity test was performed on the gel filtration
fractions. To this end 1/50 (10 𝜇L) of each collected fraction
was supplemented to a final volume of 12.1 𝜇L with spermi-
dine, DTT, rNTPs, and RNAse inhibitor (at concentrations
described for the previous activity tests) and ∼20 ng DNA.
The samples were incubated at 37∘C for 2.5 hours before
electrophoresis on 1.8% agarose gels. The 2.137 nmol Bio-T7
RNAP control was tested with ∼115 ng PCR-amplified DNA
template from pJT512.
2.9. Single Molecule Assay. A 3,250 bp piece of 𝜆-DNA was
synthesized by PCR using the primers:
5
󸀠-TTTTGAATTCAAAAAACCCCTCAAGAC-
CCGTTTAGAGGCCCCAAGGGGTTCTCATGC-
TGAAAACGTGGTGTACCGGC-3󸀠;
5
󸀠-TTTTTTAAGCTTGGACCTATCTGCCCG-
TTCGTCCCGTCGTT-3󸀠.
This DNA piece was inserted between the EcoRI and
HindIII of the plasmid pGEM4Z (Promega) downstream of
the T7 promoter. Using this plasmid pLJP1 as a template, a
∼3,000 bp DNAwas constructed with biotin and digoxigenin
labels at the ends using the following primers:
5
󸀠-Bio-TGTGATGCTCGTCAGGGGGGCGGAGC-3󸀠
5
󸀠-Dig-TTCTCATGCTGAAAACGTGGTGTA-
CCGGC-3󸀠.
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Figure 3: Activity test of purified QD : T7RNAP complexes. Lanes 1–3 and C1–C3 show the activity of 6𝜇L of the flow-through (F) and of
the washed avidin resin (A). In lane 1 a total amount of 0.13 nmol Bio-T7 RNAP was used, in lane 2 0.091 nmol, and in lane 3 0.052 nmol. In
all lanes 1–3 the amount of QDs was 0.01 nmol. C1, C2, and C3 are parallel controls of lanes l, 2, and 3, respectively, using the same amount of
Bio-T7 RNAP but without QDs. Lane 4 shows the activity of 0.026 nmol free Bio-T7 RNAP, lane 5 1 pmol QDs alone, and lane 6 is a 100 bp
DNA ladder. The red arrow marks the RNA product, green arrow marks DNA template, blue arrow marks QD : T7RNAP bands, and yellow
arrow marks bands of free QDs. The material lighting up in the slots in the A lanes is the avidin resin unable to move into the gel, compared,
for example, to lane 2A in Figure S3.
TheDNA product was purified with QIAquick Gel Extra-
ction Kit. At ∼500 bp from the biotinylated end, the DNA
construct had a T7 promoter. There was no terminator site
present.
A perfusion chamberwasmade by placing parafilm form-
ing a 20–25𝜇L well on a 60 × 24mm glass slide and adding
a 50 × 24mm glass slide as lid. The chamber was heated
such that the parafilm melted to the glass surfaces. To coat
the surface with antidigoxigenin 20𝜇g/mL antidigoxigenin
in TE (10mM Tris-HCl (pH 8), 1mM EDTA) was flushed
into the chamber and left at 4∘C overnight or at least 1
hour at 25∘C. To minimize unspecific bindings to the glass
surface transcription buffer containing 2mg/mL 𝛼-casein
was flushed through the chamber and incubated for 1 hour
at 25∘C. 10 nM of the DNA solution was flushed into the
chamber and incubated for 30 minutes at 25∘C such that
the digoxigenin-labeled end of the DNA tether could bind
to the antidigoxigenin-coated surface. 2mg/mL 𝛼-casein in
transcription buffer was flushed into the chamber and left
at 25∘C for 30 minutes to block unspecific bindings. Finally,
QD : T7RNAP complexes (2.6 nM Bio-T7 RNAP and 1 nM
QDs) in transcription buffer with 2mg/mL BSA, 2mg/mL
spermidine, 2mM of each ribonucleotides, and 10mM DTT
were flushed into the chamber, and the chamber was sealed
with vacuum grease. The controls were processed similarly
but without ribonucleotides in the transcription buffer.
The samples were investigated using an inverted Leica
microscope. A mercury lamp was focused with an oil
immersion objective (Leica HCX PL APO 100 ×NA= 1.4 oil,
∞ CS). To image the light emitted from the 605 nm QD
we used a custom made filter cube (Leica HQ420/40x +
1064, z440/1065rpc, and HQ605/40m-2p) which allowed the
420 nm light from the mercury lamp to be reflected up
to the sample and only allowed the emitted 605 nm light
to be transmitted to the EMCCD camera (Ixon, Andor).
The images were analyzed with ImageJ and custom made
Matlab routines. In addition, we performed centroid tracking
of the tethered QDs using the ImageJ tracking routine
Spottracker2D [28].
3. Results and Discussion
3.1. In Vivo Biotinylation. The T7 RNAPs were biotinylated
in vivo with a procedure that parallels the method used for
biotinylating a lambda phage subsequently labeled by a QD
[29]. The biotinylated T7 RNAPs were purified using an
agarose bead assay. The amount of biotinylated T7 RNAPs
was quantified using an avidin-coated resin and estimated to
be 95–99% of the total (Figure S1).
After in vivo biotinylation of T7 RNAPs we tested that
they were still active. The activity was verified by inspecting
the strong band at the expected weight of the product in
lane 4 (Figure 3, red arrow). As native T7 RNAP did not
bind the avidin resin, seen by comparing lane 3(F) to lane
3(A) (Figure S3), the conjugation of the avidin resin and
Bio-T7 RNAPs is mediated by the biotin-streptavidin bond
only. The QD : T7RNAP complexes were formed by mixing
the Bio-T7 RNAPs with streptavidin-coated QDs. In order
to purify the QD : T7RNAP complexes they were mixed with
an avidin resin, with the goal of capturing possible Bio-
T7 RNAPs which did not bind to QDs. The suspension
was filter centrifuged using a 0.45𝜇m filter (Figure 2) and
the QD : T7RNAP complexes would be present in the flow-
through. Free QDs would also pass the filter and be present
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Figure 4: Gel filtration of QD : T7RNAP complexes. This experiment was performed to exclude the possibility that the active Bio-T7
RNAP was bound to streptavidin (and not to QDs). (a) Control without QDs using 2.137 nmol Bio-T7 RNAP, (b) control without QDs
using 0.385 nmol Bio-T7 RNAP, and (c) 0.385 nmol Bio-T7 RNAP + 0.075 nmol QDs (Bio-T7RNAP :QD ≃ 5 : 1). All three graphs show the
absorption of 280 nm light as function of time (left axis) as well as the conductivity (right axis). In all three experiments the sample was filtered
through a Superose 6 10/300GL column at a flow rate of 0.5mL/minute, and fractions of 0.5mL were collected from 11 to 40 minutes. In each
of panels (a), (b), and (c) an inserted gel shows the activity found in the individual fractions. Fraction 32 of panel a is a positive control of
Bio-T7 RNAP activity.The DNAMWmarker used (left lane in all three inserted gels) was from top 3 kbp, 2 kbp, 1.5 kbp, 1.2 kbp, 1 kbp, 900 bp
800 bp, 700 bp, 600 bp, and so forth. Equal amounts of the DNA MW marker were loaded on each gel. Bio-T7 RNAP (103 kDa) was eluted
at 33.2 minutes (fraction 24) and QDs at 24 minutes (fraction 15). In a (not shown) calibration E. coli GlyS (224 kDa) eluted at 28.4 minutes,
Dextran blue at 14.5 minutes (fraction 5), and 70 S ribosomes (∼3000 kDa) at 20.8 minutes (fraction 13).
in the flow-through as well as possible streptavidin:T7RNAPs
released from the QDs. There has been earlier attempts to
tag T7 RNAPs [18], but the activity of the protein, when
conjugated to a QD, was not confirmed.
3.2. Activity of Ensembles of QD : T7RNAP Complexes. The
activities of the purified QD : T7RNAP complexes and the
corresponding controls without QDs were investigated using
normal gel electrophoresis (Figure 3).TheRNAproducts (red
arrow) from the flow-through (F) and avidin resin (A) are
shown for Bio-T7 RNAP concentrations in the initial binding
mixture of, respectively, 0.13, 0.091, and 0.052 nmol in lanes
marked 1, 2, and 3 and QD concentrations of 0.01 nmol. This
corresponds to QD : T7RNAP ratios of about 1 : 13, 1 : 9 and
1 : 5, respectively. The corresponding controls, without QDs,
are shown in lanes marked C1, C2, and C3. There is a clear
band denoting the existence of an RNA product in all lanes
originating from QD : T7RNAP complexes and in all control
lanes, albeit, only in the avidin resin (A) of the latter. This
verifies that the RNA product present, for example, in lane
3 (F) originated fromQD : T7RNAP complexes only since no
RNA product is present in the flow-through of C3. This also
shows that the surplus of free Bio-T7 RNAPs is efficiently
captured by the avidin resin. Hence, we conclude that the Bio-
T7 RNAP is indeed active when bound to a QD.
It is clear from lanes 1, 2, and 3 that the majority of the
QDs passed the 0.45𝜇mfilter and showed up on the gel in the
F columns as two distinct bands (blue arrow) at 1500–1700 bp
as earlier reported [30]. Interestingly, the QDs with Bio-T7
RNAPs attached migrate further than the QD alone; to see
this compare lane 5 (yellow arrow) to lanes 1, 2, or 3 (F) (blue
arrow). This is probably because the net charge of the Bio-T7
RNAPat pH8.5 (pHof the agarose gel buffer) is−5, and there-
fore the QD : T7RNAP complex migrates faster towards the
anode during electrophoresis than the free QDs. The agarose
gel pore size was relatively large in comparison to the size of
the approximately spherical QD : T7RNAP complex. Hence,
the fact that one or possibly more charged Bio-T7 RNAPs
are attached and thereby cause the complex to move faster in
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the field has a larger influence on the overall migration than
the incremental increase in effective diameter [31].
QDs are only present in the flow-through (F) of lanes 1,
2, and 3 (Figure 3), confirming that the majority of the QDs
passed the filter and did not stick to the avidin resin. On the
basis of the intensities of the bands originating from the RNA
products of F and A we estimated a ratio 3-4 : 1 of RNAPs to
QDs.This ratio is in accordance with a recent report on biotin
binding to the same type of QDs [32].
The total amount of RNA product in the presence of
QDs, lane 3, corresponds well with the RNA product in the
control without QDs, lane C3 (same initial Bio-T7 RNAP
concentrations). The intensities of the bands with RNA
product (red arrow) in lane 3 (F +A)were quantified (ImageJ,
Gel Analyser) and compared to the band with RNA product
(red arrow) in C3. The two samples differed in intensity
by ∼5% only; hence, the Bio-T7 RNAP retained similar
activity whether bound to QDs or to the avidin resin. The
fact that the Bio-T7 RNAP also binds very well to avidin-
coated agarose beads (Figure 3 lanes C1–C3) while retaining
enzymatic activity proves the generality of the method; the
Bio-T7 RNAPs retain activity though bound to other types of
avidin-coated handles than a QD.
To estimate the activity loss due to QD conjugation we
first determined if our activity assay responded to different
polymerase concentrations (Figure S2). Next, we compared
the activity of the QD : T7RNAP complex to the nonconju-
gated Bio-T7 RNAP (lane 1 (F +A) to lane 4 in Figure S3) and
corrected for dilutions of Bio-T7 RNAP in lanes 1 to a concen-
tration of approximately 0.013 nmol.This comparison showed
that the QD : T7RNAP complex lost at most ∼15% of its
activity in the experiment shown in Figure S3. However, upon
repeating the experiment 21 times with an independently
purified protein batch, we found an average activity loss of
(42±15)% (mean± STD) uponQD conjugation. Our activity
test of QD-bound RNAPs is an indirect method of measuring
the purity of complexes compared to gel purification [33].
However, running the complexes through an avidin resin is
still reliable, time saving and requires very little preparation.
3.3. Gel Filtration of QD : T7RNAP Complexes. To exclude
the possibility that the active Bio-T7 RNAP was only bound
to streptavidin (and not to QDs) released from the stock
solution of streptavidin-coatedQDs, wemixed Bio-T7 RNAP
andQDs in amolar ratio of 5 : 1 and performed a gel filtration
on a Superose 6 column (Figure 4). This type of column
facilitates the separation of highmolecular weight substances
and molecules in the particle size range relevant for ribo-
somes andQDs.The goal of this experiment is to compare the
Bio-T7 RNAP activity in the fractions where QDs eluted to
the activity in the fractions where streptavidin:Bio-T7 RNAP
is expected to elute. In the experiment three different gel
filtrations were performed, two controls without QDs with
different Bio-T7 RNAP concentrations and one with QDs
present.The two controls without QDs were performed using
2.137 nmol Bio-T7 RNAP (Figure 4(a)) and 0.385 nmol Bio-
T7 RNAPs (Figure 4(b)), respectively. The Bio-T7 RNAPs
elute at 37 minutes (fraction 25) clearly visible in Figure 4(a)
and just visible in Figure 4(b). Figure 4(a) shows where
free Bio-T7 RNAP elute, while Figure 4(b) is a control to
Figure 4(c), which shows the signal that can be obtained with
this low amount of Bio-T7 RNAP. Another important reason
to use a low concentration of QDs for the gel filtration was
that these experiments required a very large amount of QDs
(∼75 𝜇L) in comparison to the other experiments described
above (which each used 10 𝜇L). As QDs are still rather
expensive, it makes sense to perform the experiment with
as small an amount as possible (as done in the experiments
depicted in Figures 4(b) and 4(c)). It is unlikely that the
streptavidin tetramer would be able to bind more than
two molecules of biotin-labelled T7 RNAP due to steric
hindrance [34, 35], and the complex would maximally obtain
a molecular weight of 60 kDa (Streptavidin) + 2 × 103 kDa
(T7 RNAP) = 266 kDa. Such a complex should therefore elute
approximately at 28 minutes (fraction 19), much later than
the observed QD : T7RNAP activity that peaked in fractions
14-15 (inset of Figure 4(c)). The Bio-T7 RNAP peak is not
visible and the corresponding activity in fraction 25 was very
low compared to the early fractions. The peak at 50 minutes
is caused by oxidized DTT from the storage buffer. Due to
a relatively large spread in QD sizes (Figure S4) the Bio-
T7 RNAP activity peak actually extended up to fraction 5
where the largest QDs appeared. Hence, we conclude that
the activity observed was indeed from QD : T7RNAP. These
results also exclude the possibility that the activities seen in
our other assays originate from residual T7RNAP unbound
to QDs. Because we see the same overall amount of RNA in
fraction 6–17 of Figure 4(c) as is fraction 22–28 of Figure 4(b),
we conclude that the activity of the complex is comparable to
the activity of free Bio-T7 RNAP.
3.4. Activity of Single Molecule QD : T7RNAP Complexes. As
the QD : T7RNAP complex has a large potential for single-
molecule investigations, we also tested its activity in a typical
single-molecule assay, the tethered particle assay. In this assay
a double-stranded DNA tether (∼3,000 bp) was specifically
anchored to a surface with the free biotinylated end bound
to a reporter particle, a streptavidin-coated QD. The DNA
tether had a T7 promoter sequence 500 bp from the free end,
and this promoter was directed towards the glass surface.
The experiment and a control were conducted as sketched
in Figures 5(b) and 5(c), respectively. Intensity images of
DNA tethers on the coverslip surface (Figures 5(d) and 5(e))
were collected with wide-field fluorescence microscopy and a
sensitive camera.
Prior to every experiment we located the DNA tethers
with the reporter QD and tracked the diffusive behavior
through time to find the subpixel coordinates.Themagnitude
of the tethered particle motion contains information on the
overall length of the tether. Therefore, the diffusion was used
to verify that the observed QDs were indeed attached to
a DNA tether of ∼1𝜇m length and not, for example, an
agglomerate of 𝛼-casein which, most likely, has a shorter
tethering length. To this end we measured the root-mean-
square displacement:
𝜌 = √𝑙
2
1
+ 𝑙
2
2
, where 𝑙2
𝑗
=
1
𝑛
𝑛
∑
𝑖=1
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− 𝑥
𝑗
)
2
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Figure 5: Activity of QD : T7RNAP complexes tested in a single molecule assay. In the single molecule assay the DNA tether was biotinylated
at the free end, thus allowing a streptavidin-coated QD to attach to this end. In the control no ribonucleotides (NTPs) were present. Hence, as
the Bio-T7 RNAP requires the initiating nucleotide (GTP) for specific binding to the promoter, it is likely that the QD at the end of the tether
is the only QD affiliated with the DNA tether of the control. (a) Intensity distributions of DNA tethers with varying number of QDs attached.
Red bars denote an experiment with NTP present (𝑛 = 39), and green bars denote the control without NTP (𝑛 = 49). The concentration
of Bio-T7 RNAPs was 200 nM in both cases. (b) Sketch of the +NTP experiment where QDs are attached both at the biotinylated end of
the tether and as QD : T7RNAP complexes elongating along the tether. (c) Sketch of the −NTP control, only a single QD is attached at the
biotinylated 5󸀠 end of the tether. (d) Image of a typical +NTP experiment where QDs are actually seen at different locations along the tether.
(e) Image of a typical −NTP control, only a single QD is visible. Scale bars in (d) and (e) are 500 nm.
Here, 𝑥
𝑗
, 𝑗 ∈ {1, 2}, is the position of one of the two orthogo-
nal dimensions of the projected surface plane, 𝑥
𝑗
is the mean
position, and 𝑛 is the number of data points in the time
series. The root-mean-square displacement of QDs attached
to the free end of the DNA tether was measured: 𝜌
−NTP =
233 nm± 56 nm (mean ± STD) (𝑁 = 30). The result is in
accordancewith the one reported for aQD attached to aDNA
tether of similar size [36].
For the actual experiment QD : T7RNAP complexes were
added to the sample together with the required ribonu-
cleotides (NTPs). Individual QD : T7RNAP complexes thus
attached at the promoter site and started transcription along
the DNA tether. As there was no transcription termination
sequence, the QD : T7RNAP complexes were prone to accu-
mulate on the DNA tether close to the glass surface. In
the control no NTPs were present (−NTP); hence, it was
unlikely that any QD : T7RNAP complexes would attach
to the promoter or start elongating. The only fluorescent
signal expected from the control was that originating from
a streptavidin-coated QD attached to the biotinylated end of
the DNA tether (Figure 5(e)).
In the experiments with the elongating QD : T7RNAP
complexes (+NTP) the spots on the surface were significantly
more intense than in the control experiment (−NTP). Prob-
ably because the luminescent spots in the experiments origi-
nated from a single DNA tether with multiple QDs attached,
only one QD would attach to a DNA tether in the control
experiments. As the DNA tether itself performed thermal
fluctuations in and out of the focal volume and the QD also
exhibited blinking, the resulting intensity time series (with
total length ∼200 s) had significant intensity fluctuations. In
the analysis we used the window of 20 frames (∼5 s) of each
time series around themaximum intensity.The average inten-
sity, 𝐼, of the window was normalized to the intensity average
of a time series originating from the control (−NTP), 𝐼
0
. The
measured values of 𝐼/𝐼
0
both for the experiment (red bars)
and for the control (green bars) are shown in Figure 5(a).The
intensity distribution of the control is very narrow and peaks
around a value of 1, consistent with the expectation that only
a single QDwould attach to the tether.The intensity distribu-
tion of the experiment (+NTP) is significantly broader, scat-
tered, and consistent with an average accumulation of 5 QDs
per tether (at a concentration of 200 nM Bio-T7 RNAPs).
Hence, we conclude that the individual QD : T7RNAP com-
plexes are indeed active; in the presence of NTP they bind to
the promoter and accumulate on the DNA tether.
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4. Conclusions
We showed that the viral T7 RNAP could easily be effi-
ciently biotinylated while retaining activity. In addition, we
showed that upon attachment of a streptavidin-coated QD
the QD : T7RNAP complex still retains activity. In particular,
we showed how to purify QD : T7RNAPs from a solution
of unbound RNAPs. As the conjugation and purification
assays presented in this studywere simple andhighly efficient,
the devised technique is recommendable for attachment and
purification of QDs to Bio-T7 RNAPs. In comparison to the
E. coli RNAP the viral T7 RNAP is simple as it only consists
of a single polypeptide chain and has a short promoter
recognition sequence. The simplicity of the T7 RNAP as
well as its efficiency has paved the way for high production
of specific protein products [6]. Anyhow, only few single-
molecule investigations of the T7 RNAP exist [37–40] in
comparison to the detailed knowledge obtained on the single
molecule level concerning the fundamental properties, for
example, transcription velocity, stalling force, pausing events,
backtracking, of E. coli RNAP. With the techniques here
presented it will be possible to uncover the action of T7 RNAP
even at the single-molecule level.
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